$SNSS News Article - Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA https://marketwirenews.com/news-releases/vira...00347.html
(0)
(0)
Viracta Therapeutics Inc. (VIRX) Stock Research Links